SCHEMBL5793373

SCHEMBL5793373

CCCNc1ccc2ncsc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.48
RAB9A P51151 7/20 0.48
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
IRAK4 Q9NWZ3 5/20 0.48
ALDH1A1 P00352 1/20 0.47
PKM P14618 1/20 0.47
TAS1R3 Q7RTX0 1/20 0.46
TAS1R1 Q7RTX1 1/20 0.46
LRRK2 Q5S007 1/20 0.43
CFTR P13569 1/20 0.42
TRPM5 Q9NZQ8 1/20 0.42
POLB P06746 1/20 0.42
KDM4E B2RXH2 1/20 0.41
HKDC1 Q2TB90 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
QPCT Q16769 1/20 0.41
SYK P43405 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28549099 0.89 IRAK4 (0.46) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL12256522 0.87 NPC1 (0.50) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL23510553 0.83 NPC1 (0.48) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL28147512 0.80 NPC1 (0.47) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL12332459 0.79 IRAK4 (0.48) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL3780938 0.79 NPC1 (0.56) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL11935027 0.79 NPC1 (0.41) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL12257145 0.78 NPC1 (0.46) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL616687 0.78 IRAK4 (0.51) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL28086794 0.77 TRPM5 (0.45) NPC1RAB9AMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109596756-A Detection method in relation to substance in a kind of composition and Pramipexole starting material 成都倍特药业有限公司 2019-04-09 CN disclosed
WO-2006012277-A2 BIOCATALYTIC PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED PRAMIPEXOLE AMR TECHNOLOGY, INC. (US) 2006-02-02 WO disclosed